Correction to: Genetics in Medicine21:2019; https://doi.org/10.1038/s41436-019-0554-6, published online 11 June 2019
In our meta-analysis, we utilized incorrect numbers of individuals for one publication (Retterer et al. 2016) due to the fact the numbers for ASD and ID groups were not independent representations. We have updated our analysis using corrected numbers based on correspondence with the first author of this paper (diagnostic yield for NDD=543/1736 as opposed to 570/2063). The updated analysis leads to the same (rounded) weighted diagnostic yield and confidence intervals (CI) as the initial publication (36% [30–43%]). The updated analysis results in the following updated values in Fig. 2: Retterer study values: N positive=543, N total=1736, study weight=5.3% and meta-analysis statistics: I2=80%, τ2 = 0.2835, p<0.01.
The study is also included in two subanalyses reported in the Results. The isolated NDD subcategory (n=21 articles), updated analysis leads to same (rounded) weighted diagnostic yield and confidence intervals as published (31% [25–38%]). For the subanalysis of mix of ID and/or ASD, the initial yield was 37% (CI: 29–46%). Following updated analysis, the yield of this subset is 39% (CI: 29–50%).
The PDF and HTML versions of the Article have been modified accordingly.
Author Contributions
These authors contributed equally: Siddharth Srivastava, Jamie A. Love-Nichols.
The original article can be found online at https://doi.org/10.1038/s41436-019-0554-6.
Article info
Identification
Copyright
© 2020, The Author(s), under exclusive licence to the American College of Medical Genetics and Genomics
User license
Creative Commons Attribution – NonCommercial – NoDerivs (CC BY-NC-ND 4.0) | How you can reuse 
Elsevier's open access license policy
Creative Commons Attribution – NonCommercial – NoDerivs (CC BY-NC-ND 4.0)
Permitted
For non-commercial purposes:
- Read, print & download
- Redistribute or republish the final article
- Text & data mine
- Translate the article (private use only, not for distribution)
- Reuse portions or extracts from the article in other works
Not Permitted
- Sell or re-use for commercial purposes
- Distribute translations or adaptations of the article
Elsevier's open access license policy
ScienceDirect
Access this article on ScienceDirectLinked Article
- Meta-analysis and multidisciplinary consensus statement: exome sequencing is a first-tier clinical diagnostic test for individuals with neurodevelopmental disordersGenetics in MedicineVol. 21Issue 11
- PreviewFor neurodevelopmental disorders (NDDs), etiological evaluation can be a diagnostic odyssey involving numerous genetic tests, underscoring the need to develop a streamlined algorithm maximizing molecular diagnostic yield for this clinical indication. Our objective was to compare the yield of exome sequencing (ES) with that of chromosomal microarray (CMA), the current first-tier test for NDDs.
- Full-Text
- Preview
00759-0&id=gr1.jpg){kind=link}